Department of Gastroenterology, Hôpital Nord, Chemin des Bourrely, 13915 Marseille cedex 20, France.
World J Gastroenterol. 2012 Apr 14;18(14):1610-5. doi: 10.3748/wjg.v18.i14.1610.
To report the results of a medical management of sphincter of oddi dysfunction (SOD) after an intermediate follow-up period.
A total of 59 patients with SOD (2 men and 57 women, mean age 51 years old) were included in this prospective study. After medical treatment for one year, the patients were clinically re-evaluated after an average period of 30 mo.
The distribution of the patients according to the Milwaukee's classification was the following: 11 patients were type 1, 34 were type 2 and 14 were type 3. Fourteen patients underwent an endoscopic sphincterotomy (ES) after one year of medical treatment. The median intermediate follow-up period was 29.8 ± 3 mo (3-72 mo). The initial effectiveness of the medical treatment was complete, partial and poor among 50.8%, 13.5% and 35%, respectively, of the patients. At the end of the follow-up period, 37 patients (62.7%) showed more than 50% improvement. The rate of improvement in patients who required ES was not significantly different compared with the patients treated conservatively (64.2% vs 62.2%, respectively).
Our study confirms that conservative medical treatment could be an alternative to endoscopic sphincterotomy because, after an intermediate follow-up period, the two treatments show the same success rates.
报告Oddi 括约肌功能障碍(SOD)经中间随访期后医学治疗的结果。
这项前瞻性研究共纳入 59 例 SOD 患者(男 2 例,女 57 例,平均年龄 51 岁)。经 1 年的药物治疗后,平均随访 30 个月后对患者进行临床再评估。
根据密尔沃基分类,患者分布如下:11 例为 1 型,34 例为 2 型,14 例为 3 型。14 例患者在药物治疗 1 年后接受了内镜下括约肌切开术(ES)。中间随访期的中位数为 29.8±3 个月(3-72 个月)。初始药物治疗的有效率分别为完全缓解 50.8%、部分缓解 13.5%和无效 35%。在随访期末,37 例患者(62.7%)的改善程度超过 50%。需要行 ES 的患者的改善率与保守治疗患者无显著差异(分别为 64.2%和 62.2%)。
我们的研究证实,保守的药物治疗可能是内镜下括约肌切开术的替代方法,因为在中间随访期后,两种治疗方法的成功率相同。